Business
Elon Musk In Krakow, Poland
Elon Musk (Beata Zawrzel/Getty Images)
Weird Money

Musk wants the court to slow OpenAI’s roll

He wants a crackdown on OpenAI allegedly telling its investors to boycott investing in other AI startups.

Jack Raines

Another bit of Elon news: on Friday, he filed a preliminary injunction against OpenAI in federal court to stop the $157 billion startup from converting into a fully for-profit business. For context, Musk, who cofounded OpenAI as a nonprofit in 2015 and left the company after a disagreement with its other cofounders over the company’s direction, already sued OpenAI twice in the last year, first in a San Francisco court in March, before dropping that lawsuit and refiling a new suit in federal court in August.

In the previous suits, Musk alleged that he was “courted and deceived” by Sam Altman and OpenAI President Greg Brockman to cofound a nonprofit while Altman always intended to build out a for-profit company under the surface. Musk, whose AI startup xAI is a competitor to OpenAI, has said in his latest injunction that OpenAI led a group boycott of investment capital blocking its current investors from investing in xAI, and that the company should be blocked from “benefitting from wrongfully obtained competitively sensitive information or coordination via the Microsoft-OpenAI board interlocks.”

Basically, Musk doesn’t want OpenAI to convert to a for-profit model, as it goes against the company’s charter, and he wants to prevent OpenAI from allegedly requiring investors to not invest in its competitors. Of course, he has 50 billion reasons to want to slow down OpenAI, given xAI’s recent fundraise, but it is interesting to see the CEO of the world’s most valuable auto company and one of its highest-profile AI companies playing defense in the court with one company, while he’s full-court pressing with the other.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.